Literature DB >> 17532513

An affinity-based fluorescence polarization assay for protein tyrosine phosphatases.

Sheng Zhang1, Lan Chen, Sanjai Kumar, Li Wu, David S Lawrence, Zhong-Yin Zhang.   

Abstract

Protein tyrosine phosphatases (PTPs) are important signaling enzymes that control such fundamental processes as proliferation, differentiation, survival/apoptosis, as well as adhesion and motility. Potent and selective PTP inhibitors serve not only as powerful research tools, but also as potential therapeutics against a variety illness including cancer and diabetes. PTP activity-based assays are widely used in high throughput screening (HTS) campaigns for PTP inhibitor discovery. These assays suffer from a major weakness, in that the reactivity of the active site Cys can cause serious problems as highly reactive oxidizing and alkylating agents may surface as hits. We describe the development of a fluorescence polarization (FP)-based displacement assay that makes the use of an active site Cys to Ser mutant PTP (e.g., PTP1B/C215S) that retains the wild-type binding affinity. The potency of library compounds is assessed by their ability to compete with the fluorescently labeled active site ligand for binding to the Cys to Ser PTP mutant. Finally, the substitution of the active site Cys by a Ser renders the mutant PTP insensitive to oxidation and alkylation and thus will likely eliminate "false" positives due to modification of the active site Cys that destroy the phosphatase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532513      PMCID: PMC2001261          DOI: 10.1016/j.ymeth.2007.02.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  20 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Authors:  Zhong-Yin Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 3.  Pharmacological inhibitors of MAPK pathways.

Authors:  Jessie M English; Melanie H Cobb
Journal:  Trends Pharmacol Sci       Date:  2002-01       Impact factor: 14.819

Review 4.  Protein tyrosine phosphatases: prospects for therapeutics.

Authors:  Z Y Zhang
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

5.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Authors:  Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

Review 6.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

7.  Conformational and dynamic changes of Yersinia protein tyrosine phosphatase induced by ligand binding and active site mutation and revealed by H/D exchange and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  F Wang; W Li; M R Emmett; C L Hendrickson; A G Marshall; Y L Zhang; L Wu; Z Y Zhang
Journal:  Biochemistry       Date:  1998-11-03       Impact factor: 3.162

8.  Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.

Authors:  G J Parker; T L Law; F J Lenoch; R E Bolger
Journal:  J Biomol Screen       Date:  2000-04

Review 9.  Inhibitors of protein tyrosine phosphatases: next-generation drugs?

Authors:  Laurent Bialy; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2005-06-20       Impact factor: 15.336

Review 10.  Mechanistic studies on protein tyrosine phosphatases.

Authors:  Zhong-Yin Zhang
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003
View more
  3 in total

1.  A combinatorial strategy for the acquisition of potent and specific protein tyrosine phosphatase inhibitors.

Authors:  Sheng Zhang; Lan Chen; David S Lawrence; Zhong-Yin Zhang
Journal:  Methods Mol Biol       Date:  2012

2.  A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots.

Authors:  Jerry C Chang; Ian D Tomlinson; Michael R Warnement; Hideki Iwamoto; Louis J DeFelice; Randy D Blakely; Sandra J Rosenthal
Journal:  J Am Chem Soc       Date:  2011-10-17       Impact factor: 15.419

3.  Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy.

Authors:  Sheng Zhang; Lan Chen; Yong Luo; Andrea Gunawan; David S Lawrence; Zhong-Yin Zhang
Journal:  J Am Chem Soc       Date:  2009-09-16       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.